source
- Japan's PMDA Issues Guidance to Safeguard Participants in Generic Bioequivalence TrialsThe Pharmaceuticals and Medical Devices Agency (PMDA) in Japan has released new guidance aimed at protecting healthy adult volunteers who take part in generic bioequivalence studies. The document…
- Europe’s share of clinical trials falls 13.5% as Asia’s research footprint expandsThe latest data show a 13.5% drop in the number of clinical trials authorized in the EU and EEA compared with pre-pandemic levels. At the same time, Asian countries have increased their share of g…